Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?

Abstract

BackgroundIncomplete adherence to antiretroviral therapy (ART) results in virologic failure and resistance. It remains unclear which adherence measure best predicts these outcomes. We compared six patient-reported and objective adherence measures in one ART-naïve cohort in South Africa.MethodsWe recruited 230 participants from a community ART clinic and prospectively collected demographic data, CD4 count and HIV-RNA at weeks 0, 16 and 48. We quantified adherence using 3-day self-report (SR), clinic-based pill count (CPC), average adherence by pharmacy refill (PR-average), calculation of medication-free days (PR-gaps), efavirenz therapeutic drug monitoring (TDM) and an electronic adherence monitoring device (EAMD). Associations between adherence measures and virologic and genotypic outcomes were modelled using logistic regression, with the area under the curve (AUC) from the receiver operator characteristic (ROC) analyses derived to assess performance of adherence measures in predicting outcomes.ResultsAt week 48 median (IQR) adherence was: SR 100% (100–100), CPC 100% (95–107), PR-average 103% (95–105), PR-gaps 100% (95–100) and EAMD 86% (59–94), and efavirenz concentrations were therapeutic (>1 mg/L) in 92%. EAMD, PR-average, PR-gaps and CPC best predicted virological outcome at week 48 with AUC ROC of 0.73 (95% CI 0.61–0.83), 0.73 (95% CI 0.61–0.85), 0.72 (95% CI 0.59–0.84) and 0.64 (95% CI 0.52–0.76) respectively. EAMD, PR-gaps and PR-average were highly predictive of detection of resistance mutations at week 48, with AUC ROC of 0.92 (95% CI 0.87–0.97), 0.86 (0.67–1.0) and 0.83 (95% CI 0.65–1.0) respectively. SR and TDM were poorly predictive of outcomes at week 48.ConclusionEAMD and both PR measures predicted resistance and virological failure similarly. Pharmacy refill data is a pragmatic adherence measure in resource-limited settings where electronic monitoring is unavailable. Trial registration The trial was retrospectively registered in the Pan African Clinical Trials Registry, number PACTR201311000641402, on the 13 Sep 2013 (www.pactr.org). The first participant was enrolled on the 12th July 2012. The last patient last visit (week 48) was 15 April 2014Electronic supplementary materialThe online version of this article (doi:10.1186/s12981-017-0138-y) contains supplementary material, which is available to authorized users.

Prospective plasma efavirenz concentration assessment in Chinese HIV‐infected adults enrolled in a large multicentre study

“…The median age was 33 years, 73.6% of participants were male and 73.6% of participants were Han Chinese. The median (IQR) body weight was 60 (54, 67) kg, and the median body mass index was 21 (20,24) kg/m 2 . The proportions of patients with HBV and HCV coinfection were 10.3% and 2.4% respectively.…”

Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study

“…In China, mobile phone-based SMS reminders are reported to be acceptable and useful in establishing antiretroviral adherence routines [29]. In South Africa, adherence measured by a real-time monitoring technology emerged as one of the best predictors of antiretroviral drug resistance and virological failure [30]. In the same setting in Uganda, a mobile adherence monitoring intervention composed of real-time adherence technology and SMS reminders was reported to be acceptable [19] and to improve adherence to antiretroviral therapy [18].…”

Mechanism of Change in Cognitive Behavioral Therapy for Body Image and Self-Care on ART Adherence Among Sexual Minority Men Living with HIV

“…Each time the device is opened, a signal is sent to a server in Cape Town, South Africa for recording and access. In previous studies, Wisepill devices have demonstrated feasibility, acceptability, construct validity, and have been found to predict loss of viral suppression [27–29]. Participants were instructed to place inside the device the medication that was most difficult to take or the one taken most frequently if they were unable to fit their full medication regimen into Wisepill.…”